DatasetName,DENND4B_S(1211) DENND4B_S(3) DENND4B_S(736),DENND4B_S(1068) DENND4B_S(1071) DENND4B_S(1092) DENND4B_S(1103) DENND4B_S(5) DENND4B_S(731) DENND4B_S(732) DENND4B_S(747) DENND4B_S(953) DENND4B_T(1066) DENND4B_T(1294),DENND4B_S(1066) DENND4B_S(1074) DENND4B_S(735) DENND4B_S(947)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,,,
FSO2013_Ratio M/L normalized Rep3,,0.49718047343994487,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,,,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,,,
HS2024_6_B_T3,0.5944688971716791,0.4928004651856247,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,,0.4948951395146146,0.40996359541668603
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,0.5782675317622977,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,0.6118822548907883,0.4891204691720329,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,0.5364278933757652,,
FSO2013_Ratio M/L normalized Rep1___1,,0.49505831024877983,0.41054837458280524
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,,0.4666362827271422,
RB2022_5_PreEndurance,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,,0.4811955183878751,
WZ2023_Pu_010_30min,0.5306334457222256,0.490119441775301,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,,,
RB2022_8_RecoveryEndurance,,0.4870362845922027,
KBE2022_Log2_Ex_14_U,0.5793150540357346,0.4792105846899563,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,,0.4945781193996375,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,0.5944352885556498,,
RB2022_5_PreSprint,,,
PG2020_Intensity 8h_C,,,
AH2018_SILAC_MR_2_N,,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,,0.4881061443127029,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.44893370367564156,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,,,
GF2025_P6_Sph,0.5772221403391516,,
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,,,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.5209528964533116,0.48848871019411905,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,,
KBE2022_Log2_Ex_34_U,0.5890401782630766,0.48335547467345213,
WZ2023_Pu_005_10min,0.5327083627003631,0.4902341663428734,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,,0.48429263871467126,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.5335065327488121,0.4899177976336597,
AH2018_SILAC_MR_2_X,,,
HS2024_4_PD_T2,0.5643278598055271,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,0.5006796251001794,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,,0.4758436521872956,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,,,
EJN2021_3_Rest_Basal,,0.4878654303578677,
CR2017_Ratio Replicate 1.3,,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,,0.46507997466523693,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,,0.47243876641623833,
HS2024_7_PD_T2,0.5205283155592336,,
FSO2013_Ratio H/L normalized Rep1___1,,0.49088830924891275,0.4069865726544584
AH2018_LFQ_1_C,,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,0.5522960988513291,0.48173095885569117,0.42266879335211033
HS2024_3_B_N1,0.589387294870437,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.5364601701977251,0.4912591401097026,
CK2022_11 40-1,,0.4836782308614893,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,,0.4723400157537292,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,,,
FSO2013_Ratio H/L normalized Rep2,,0.48907701289338146,0.4039567758919532
WZ2023_Pu_005_20min,0.5399091100990546,0.49239328575139324,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,,0.47691521676961063,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,0.5500795035528255,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,0.5617292492183795,0.4998273140259846,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,0.593525232610136,,
FSO2013_Ratio M/L normalized Rep3___2,,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,0.48662725765095644,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,0.6255350444648624,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,,,
CK2022_1 200-1,0.5434050836826123,0.48704974867390016,
PG2020_Intensity Mock_10h_D,,,
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,0.5857701931179634,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.508488694915641,
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,,,
PG2020_Intensity 2h_C,,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,,,
KBE2022_Log2_Ex_8_T,0.6010870598762136,0.48335355802965796,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,0.5730150964295362,,
RN2012_L11,,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,0.6279907022721241,0.5110810966451035,
AH2018_LFQ_M_2_C,,,
CK2022_3 40-1,,0.4760370412113342,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,0.5662516292871587,,
YA2020_Reporter_intensity_Cancer_No.5,,,
HH2022_Reporter intensity 8,,,
ZQ2022_N2,0.5308664022090526,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,,0.494431916140625,
EJN2021_5_Rest_Basal,,0.488565366691565,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,0.5650922653125374,0.48630939813898966,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,,0.46473315825061723,
YA2020_Reporter_intensity_Normal_No.1,,,
HS2024_3_B_T1,0.5788289083660643,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,0.4800577607704254,
RB2022_1_PostEndurance,,,
CR2017_Ratio Replicate 3,,0.49277926571275016,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,0.5727773025626629,,
HS2024_8_I_T3,0.5314208576439157,0.4807025487687299,
CF2017_EOC 3,,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,0.5403183127605357,,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.5273031972174251,0.4875919987703947,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,,0.4771165059476799,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,,,
KS2014_Intensity N3,,,
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,,,
FSO2013_Ratio H/M normalized Rep2,,0.483990531121143,
RAM2015_Log2 A,,,
HS2024_8_PD_T1,0.5279871261991683,0.49394645829991257,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,,,
KS2014_Intensity E15_2,,,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,,
HS2024_7_I_T1,0.5351547401565104,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,0.5850389568856179,,
AH2018_SILAC_M_3_X,,0.46875420560426484,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,0.5562117380132203,0.4816896250504865,0.4201482705439396
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,,0.4825521481251867,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,,0.4802163025911801,
HS2024_6_B_N1,0.5371249720344925,,
KBE2022_Log2_Ex_27_T,0.5691599310716801,0.47683640507107145,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.5793616494337042,0.47994118469473696,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,,0.4886581398011789,
AH2018_SILAC_IT_3_X,,0.46895880843713905,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,,
FSO2013_Ratio M/L normalized Rep2,,0.49361780105141917,0.4041372922035008
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,,,
SR2019_HCC1954_Biol_repl_2,,,
CK2022_14 40-1,,0.4795444908626873,
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,,
DL2023_control-1,,,
AR2021_ALG 10 μM,,,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,,0.46298827851232555,
EJN2021_4_Rest_Ins,,0.48420800478016995,
RN2012_H05,,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,0.5381528087686832,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,0.49140933663419745,
EJN2021_1_Rest_Ins,,0.48597302640533324,
HH2022_Reporter intensity 3,,0.486132093684429,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,,0.4802387163301968,
JW2021_After_3,,,
GF2025_P8_Sph,0.557578769208404,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,,0.47069198811689533,
CK2022_11 200-1,0.5799857323179899,0.49874679740242095,
CK2022_12 200-1,0.5803653218290843,0.4967826838791644,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,,0.49284694088878694,
WZ2023_Su_010_20min,0.5046899749068179,0.4906700604655794,
AH2018_TMTMS2_2_N,,0.4956095642857866,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,0.6042018023531477,0.4854117639739369,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.5198440941774051,0.49615847022361614,
AH2018_TMTMS3_Pool,,0.496104020925469,
KS2014_Intensity N4,,,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,,,
CK2022_14 200-1,0.5507315590513127,0.4876118287594565,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,,0.49566106330257753,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,,0.4962225163550235,
AST2020_anti-CD3+PDL2.2,,,
PG2020_Intensity Mock_10h_A,,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,,0.4865646904629117,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,,,
GF2025_P1_Adh,0.5298372263082163,,
GF2025_P1_Sph,0.6071483164735297,,
EJN2021_5_Ex_Basal,,0.4845391253904202,
HS2024_7_I_T3,0.5103463387201624,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.49572410948107754,0.48988768224506046,
CF2017_EOC 1,,,
CK2022_3 200-1,0.5445615668299648,0.4876621387157585,
AH2018_LFQ_IT_3_C,,0.4768868019262717,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,0.52120613956088,,
HS2024_5_B_T1,0.5871896614863413,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,0.5436340350825216,,
RB2022_6_PreStrength,,,
CK2022_2 40-1,,0.4779274774800161,
RB2022_1_PostSprint,,,
CK2022_4 200-1,0.5448814379369945,0.4880749275696595,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,,,
AR2021_ALG 1 μM,,,
HS2024_4_B_T1,0.5517193441951447,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,,0.4865455037543558,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,0.5728773209784884,,
CK2022_9 16-1,,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,0.5502159882699397,0.487369407748485,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,,
CK2022_16 16-1,,,
FS2019_db/db3,,,
CK2022_15 40-1,,0.47908575612734533,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.5410247341218944,0.491989316082106,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,0.5944505963219943,0.48499817157679675,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,,0.4723816643043246,
HS2024_5_PD_T3,0.5714105062038949,,
AH2018_TMTMS3_3_X,,0.49854630655016813,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,0.6088056922043893,0.4889151072984265,
AH2018_LFQ_M_1_N,,,
KBE2022_Log2_Ex_27_U,0.5773466376384792,0.47810666459035944,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,,0.49149213095859223,
YA2020_Reporter_intensity_Normal_No.4,,,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,,,
RN2012_L13,,,0.42406832252579185
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,0.5890969087656052,0.4815857113437877,
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,0.5978588624744255,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,0.5370894157332672,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,,0.4868911872471004,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,,0.48407967731536056,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,,0.5067526566293785,
HH2022_Reporter intensity 6,,0.4844131062001282,
RB2022_2_RecoveryStrength,,0.48355121340894575,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,,0.49539272845087345,
GF2025_P3_Adh,0.5368177066891634,,
SR2019_JIMT1_Biol_repl_2,,,
AH2018_TMTMS2_1_C,,0.4949298932539774,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,,0.4821347772579854,
KBE2022_Log2_Ex_19_U,0.5844733128785782,0.4808791681493503,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,,,
AST2020_Control,,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,,0.4933689435611528,0.4045787850758314
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,,,
RB2022_7_RecoverySprint,,0.4960783378081389,
YA2020_Reporter_intensity_Normal_No.3,,,
HS2024_8_B_T2,0.5244693589653241,,
AH2018_LFQ_1_X,,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,,,
HH2022_Reporter intensity 1,,0.48720195678741746,
HH2022_Reporter intensity 2,,0.48728473216266743,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,,,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,0.5194166677014371,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,,0.49919995755419694,
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,,,
CR2017_Ratio Replicate 2,,0.4886642840179952,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,,0.49040876802495553,
AR2021_KD 72h,,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,0.5850588016620125,0.48521585515379845,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,,0.49518456478697476,
KBE2022_Log2_Ex_9_U,0.6045151163524016,0.48524485201794204,
AH2018_SILAC_M_3_N,,0.4676242402236395,
KBE2022_Log2_Ex_13_T,0.59769664917982,0.48589110926283363,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,,,
CF2017_OSE 29,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,0.573082008041368,,
PG2020_Intensity 10h_A,,,
RN2012_L12,,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,,0.47165851827234584,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,,0.49193731998384427,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,,0.4794777812668253,
RB2022_7_RecoveryEndurance,,0.4838590166996744,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,,0.4823802334612683,
TM2022_S2.12h.B,,,
RN2012_L15,0.5552620653440183,0.49897848078662155,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,,
FSO2013_Ratio H/M normalized Rep2___2,,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,0.597781013466049,0.4847336560958849,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,,,
RB2022_1_PreSprint,,,
HS2024_4_I_N1,0.5931298452132328,,
CK2022_7 200-1,0.5499388992327628,0.4884862885178267,
CK2022_5 200-1,0.5457841618193814,0.4872883789669331,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,,0.489233443999665,0.4041209248818262
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,0.4979622712976078,
AH2018_LFQ_2_C,,,
AH2018_SILAC_MR_1_X,,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,0.5787270031409492,0.48003633534275364,
AH2018_SILAC_3_C,,0.4716519297508624,
EJN2021_5_Rest_Ins,,0.4854583067060156,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,,0.4901947699007978,
CK2022_4 16-1,,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,,0.48371274275286713,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,,
FSO2013_Ratio H/L normalized Rep3,,0.49458711760505997,0.4189403357560368
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,0.5227160332580031,,
KBE2022_Log2_Ex_9_T,0.5987685672808354,0.48384017496544884,
AH2018_SILAC_IT_2_N,,0.46311638968135593,
AH2018_SILAC_IT_1_X,,0.4744281950896548,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,0.5178022193242598,,
UK2020_UA_2,,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,0.5638288932942044,,
WZ2023_Pe_025_20min,0.522800729533145,0.48548314798278314,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,,,
HS2024_4_I_N2,0.6210361376897707,,
AH2018_TMTMS2_3_N,,0.49564473136189624,
RN2012_H06,0.5769629193315129,0.5054578676342947,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,0.5804209855535566,,
WZ2023_Su_005_30min,0.5200156567968754,0.49142492583404584,
SR2019_HCC1419_Biol_repl_4,,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,,0.4943686025876023,
WZ2023_Su_025_10min,0.5222785195589458,0.4921910309493636,
AH2018_LFQ_IT_4_X,,0.46508745164916365,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.5672586315898542,0.4940294665553955,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,,0.45688768306116356,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,,,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,,
LY2019_P7+,0.5493447197654807,0.4860090621648492,
EP2017_Untreated R#1 normalized log2 ratio,,0.5422193593885168,
RN2012_L10,,,
PG2020_Intensity 4h_C,,,
EP2017_Mitotic R#3 normalized log2 ratio,,0.5127176333991973,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,0.5932386288488803,0.483157890379454,
RB2022_8_PostStrength,,,
AH2018_SILAC_IT_2_X,,0.4699848661487947,
HS2024_4_B_T3,0.5672746601835609,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,0.5357817643286059,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,0.51983341243725,,
KBE2022_Log2_Ex_6_U,0.5346476499489033,0.4833730733481548,0.39836432656649895
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.5521204995185655,0.48754793463371654,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.4791838367134615,
GF2025_P9_Sph,0.5694075613456189,,
CK2022_6 200-1,0.5456680558483904,0.48776290889099916,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,,0.4960175397110484,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,,,
HS2024_4_I_T2,0.5513853190695434,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,0.5803458149145041,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,0.5380908268063672,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,,,
EP2017_Untreated R#3 normalized log2 ratio,,0.5339111366085613,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.5516977717528876,0.48889942054914565,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,,0.49751152997745085,
RB2022_7_PostEndurance,,0.4894177564955537,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.4401343405124037,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,,0.47682088626836516,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,0.5627088097291338,,
KBE2022_Log2_Ex_29_T,0.6048613650122383,0.48069918757463553,
HS2024_7_I_T2,0.5023475392038448,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,0.6005875122693322,0.49343013631496385,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,,0.4839151463139116,
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,0.49644173028016175,
AH2018_SILAC_MR_3_N,,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,,,
PG2020_Intensity CT_C,,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,0.5506683393924695,0.48438357816550526,0.4110251676299416
EP2017_Untreated R#3 log2 ratio,,0.5324697024542714,
RB2022_2_PostStrength,,0.47677110258622674,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,,0.49651300249885605,
HS2024_8_PD_T2,0.5261393759502098,0.48610343392686367,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,0.5188917608393958,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,0.5424424234615027,0.4845675085955589,0.39808325730857963
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,,,
CR2017_Ratio Replicate 2.3,,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,0.5499490648076577,,
YA2020_Reporter_intensity_Normal_No.2,,,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,0.6251202759809354,,
HS2024_3_PD_T3,0.6331675178128561,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,0.6052294927802975,0.48511628690969977,
CK2022_2 16-1,,,
RAM2015_Log2 B,,,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,,0.4869769619532897,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,0.58923647222443,0.49780151232397557,
UK2020_HCM_5,,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,0.5157557990130163,,
PG2020_Intensity Mock_10h_B,,,
WZ2023_Su_025_30min,0.5165710735334571,0.4853561241358004,
AH2018_LFQ_4_N,,,
CR2017_Ratio Replicate 1.2,,,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,0.5394826707148829,,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,,0.4849123706586966,
AH2018_SILAC_M_1_X,,,
RB2022_7_PreEndurance,,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,0.4802429035949725,0.4671631123001651,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,0.5662531568184803,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,0.6132154160771554,0.4998877668912602,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,,0.49534080963464633,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,,0.5046063412199114,
KS2014_Intensity C5,,,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,0.5847831118729983,,
RB2022_3_PostStrength,,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,0.5729558070164146,,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,,
AH2018_LFQ_2_X,,,
PG2020_Intensity 2h_B,,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,,,
KS2014_Intensity E15_3,,,
GF2025_P3_Sph,0.5875874527120942,,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.5778138985045917,0.49084007890603887,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,,0.4698945031133626,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,,0.4972131724964662,
ZQ2022_N1,0.529269210604053,,
LY2019_P6-,0.5485034493446307,0.48577962477734454,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,0.5926512688646453,0.48263654450984544,
AH2018_LFQ_3_N,,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,,,
UK2020_UA_1,,,
KBE2022_Log2_Ex_13_U,0.5832071717446851,0.4825719898289801,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,,0.4783016686390985,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,0.5555319745795044,,
WZ2023_Su_025_20min,0.519841374455485,0.494592606370948,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,0.6230722059020893,0.5061165583839242,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,,0.4883697620810166,0.402971381681971
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,,0.4804116980615029,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,,,
PG2020_Intensity 10h_D,,,
RB2022_8_PreEndurance,,,
HS2024_3_B_N2,0.6136922672499071,,
EJN2021_4_Ex_Ins,,0.4854553603894734,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,,0.4844767560435153,
EP2017_Pervanadate R#3 log2 ratio,,0.4552557601717209,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,,,
AH2018_LFQ_M_4_C,,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,,,0.42632584640349763
CK2022_6 40-1,,0.4788916690067185,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,0.5451444600808857,0.4824736972464059,0.41328533103227927
LY2019_P3-,,0.5040701170608504,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,,0.4837765376899101,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.5206269811587494,0.48726470788748893,
HS2024_8_PD_T3,0.5491317863678967,0.4932565794454034,
EJN2021_3_Ex_Basal,,0.481940732218906,
AST2020_Control.1,,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.5208067058206622,0.4869835360136064,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,0.5395381442688013,,
RB2022_1_RecoveryStrength,,,
SR2019_HCC1954_Biol_repl_4,,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,0.5490189111413848,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,,0.4967703248968315,
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,,0.49625859052262117,
HS2024_8_I_N2,0.5209383919546212,,
RB2022_3_RecoveryStrength,,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,,,
LY2019_P8+,0.6258070346548977,0.5068624207710538,
RB2022_2_RecoveryEndurance,,0.4776765923310888,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.5441101698530091,0.4910843308325101,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,0.5532571595041347,0.4820314768662455,0.4214744465889482
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,,,
LY2019_P2-,,0.49422884486650126,
AH2018_LFQ_IT_1_X,,,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,,0.4966847007147605,
WZ2023_Pe_005_20min,0.5324394834931206,0.4903778766643931,
AST2020_Control.2,,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,0.5550856951561087,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,,0.4786156797716972,
SR2019_MCF10A_Biol_repl_4,,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,,,
HS2024_5_B_T2,0.5938103336808295,,
HS2024_6_I_T1,0.5185137686248444,,
HS2024_5_B_T3,0.5748318231105417,0.5050731882771271,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,0.5885685125385332,0.48645381802522997,
AH2018_TMTMS3_3_N,,0.4951325986820827,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,,0.5187136611904732,
KBE2022_Log2_Ex_36_T,0.5994076559490286,0.4841145066006682,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.5220242038782347,0.49335761858625227,
KS2014_Intensity C2,,,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,0.5450641826239874,0.47740370331320287,0.40682895366067023
CK2022_9 200-1,0.5810786338257977,0.4999846205915748,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,0.5787676124064917,0.49852720667408595,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,0.532177468877557,,
RBK2021_1332T Late,,,
LY2019_P1-,0.576292969174501,0.49040852330251694,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,,0.5037743828417242,
HS2024_3_I_T3,0.5533384445194169,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,,,
ZQ2022_C3,0.5960596148804648,,
EJN2021_3_Rest_Ins,,0.4889911896881129,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,0.5499991856664982,0.48316721997352463,0.41123750805431825
FSO2013_Ratio H/M normalized Rep3___2,,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,,0.5409091506402284,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.5415081853554518,0.4936470340051125,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,0.5991689184430019,0.4916392803856269,
KS2014_Intensity N1,,,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,,,
HS2024_5_B_N2,0.5947197128571906,,
HS2024_5_I_N1,0.583094979162265,,
HS2024_6_I_N1,0.5437330115902504,,
AR2021_KD 48h,,,
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,,,
HS2024_5_I_T1,0.5689861584557182,0.4890807043621735,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,,,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.5455722442664905,0.491429916306452,
KBE2022_Log2_Ex_29_U,0.599291037408601,0.48353051288195287,
HS2024_7_B_T1,0.544184228240574,,
AH2018_LFQ_M_2_X,,,
AH2018_LFQ_IT_4_N,,0.46474170638808965,
CK2022_15 200-1,0.5524169940305427,0.4879103447714331,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,0.5898641002769095,0.4812512074361124,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,,0.47663192186763226,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,0.5438817046097307,0.48761361811236553,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.5000989373516999,0.4931508179610045,
RN2012_H01,,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,,0.48688241987774905,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.45301811515324797,
HS2024_8_B_T3,0.5169335740153737,,
YA2020_Reporter_intensity_Cancer_No.3,,,
KBE2022_Log2_Ex_44_U,0.60476862266678,0.4903572277987313,
WZ2023_Pe_010_20min,0.5352984216936214,0.4853626542504411,
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,,,
FSO2013_Ratio H/M normalized Rep3___1,,0.4905969245248072,
AH2018_SILAC_M_3_C,,0.4731526038439956,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,,0.47763453604975953,
AH2018_SILAC_M_2_X,,0.4730979743919493,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,0.5498597839686817,0.48317681699569787,0.4102554306572477
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.5429966983328846,0.49488739942265364,
PG2020_Intensity 6h_C,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,,,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,,0.49632307262114694,
CK2022_15 16-1,,,
CK2022_3 16-1,,,
LY2019_P4-,0.5649573515953709,0.496563642649684,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,0.5954337086543794,,
GF2025_P8_Adh,0.561893628496435,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,0.6077666141750772,,
CK2022_10 16-1,,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.5876313701127058,0.47778425633722404,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,,0.48710507649457174,
EJN2021_2_Ex_Basal,,0.4888064990370205,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,,,
AR2021_L41 10 μM,,,
CF2017_EOC 2,,,
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,,,
RB2022_7_PreSprint,,0.4822009933825671,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,0.6204089916641504,,
CK2022_6 16-1,,,
ZX2022_CB treated Replicate 1,,,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,,0.48734044900965096,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,,0.4945402538915662,
AR2021_L41 1 μM,,,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,,0.49449769375850844,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,,,
KS2014_Intensity C4,,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,0.5996042820777353,0.48698584903171865,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,0.5665894002104669,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,,,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,0.4880446442052777,
AH2018_SILAC_IT_3_C,,0.4763027787392941,
WZ2023_Pu_025_10min,0.5458070657001116,0.4893931107381203,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,,0.49682113833947494,
SR2019_JIMT1_Biol_repl_4,,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.5311133580764898,0.4911160118242171,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,0.47070289887588856,
KS2014_Intensity C6,,,
ZQ2022_N3,0.5345252561162562,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,,0.4840147600904067,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,,,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,,0.4800012329701379,
AH2018_SILAC_IT_2_C,,0.4790220856494892,
CK2022_5 40-1,,0.47844083694653033,
AH2018_LFQ_3_X,,,
UK2020_UA_3,,,
LY2019_P7-,0.5513099009578992,0.48654502067187233,
GF2025_P5_Adh,0.546671376136173,,
RB2022_1_PostStrength,,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,,0.4949315163083,0.419447575399082
SR2019_HCC1954_Biol_repl_3,,,
CR2017_Ratio Replicate 2.2,,,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,,,
ZQ2022_C1,0.5919350678018253,,
CR2017_Ratio Replicate 2.1,,0.48072239120331983,
PG2020_Intensity CT_B,,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,,,
YA2020_Reporter_intensity_Cancer_No.4,,,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,0.5896125446447815,,
RB2022_2_PreEndurance,,0.489415388886312,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,0.5782089739702957,0.47570038616151594,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,,,
AST2020_anti-CD3+PDL2,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,0.5825033029092669,0.47630736242155,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,,,
HS2024_8_I_T1,0.5445746934231919,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,,0.5147272527869782,
AH2018_TMTMS2_1_X,,0.4939992467353862,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,,0.4873974075959568,
HS2024_6_I_N2,0.5307320798952131,,
HH2022_Reporter intensity 4,,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,,,
HS2024_4_I_T3,0.5757479699380724,,
AH2018_SILAC_1_X,,,
PG2020_Intensity 10h_B,,,
AH2018_TMTMS3_1_X,,0.49921903535830037,
CF2017_FTE 14,,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,,
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,0.5764195777073112,0.4779108963273184,
EP2017_Untreated R#2 normalized log2 ratio,,0.5000668680988546,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,0.6206643258493766,0.5054598638240935,
HS2024_5_I_N2,0.5551950847909928,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,,0.4461010234257761,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
